Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 2/2000

01-02-2000

A pooled analysis of thyroid cancer studies. V. Anthropometric factors

Authors: Luigino Dal Maso, Carlo La Vecchia, Silvia Franceschi, Susan Preston-Martin, Elaine Ron, Fabio Levi, Wendy Mack, Steven D. Mark, Anne McTiernan, Laurence Kolonel, Kiyohiko Mabuchi, Fan Jin, Gun Wingren, Maria Rosaria Galanti, Arne Hallquist, Eystein Glattre, Eiliv Lund, Dimitrios Linos, Eva Negri

Published in: Cancer Causes & Control | Issue 2/2000

Login to get access
Metadata
Title
A pooled analysis of thyroid cancer studies. V. Anthropometric factors
Authors
Luigino Dal Maso
Carlo La Vecchia
Silvia Franceschi
Susan Preston-Martin
Elaine Ron
Fabio Levi
Wendy Mack
Steven D. Mark
Anne McTiernan
Laurence Kolonel
Kiyohiko Mabuchi
Fan Jin
Gun Wingren
Maria Rosaria Galanti
Arne Hallquist
Eystein Glattre
Eiliv Lund
Dimitrios Linos
Eva Negri
Publication date
01-02-2000
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 2/2000
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1008938520101

Other articles of this Issue 2/2000

Cancer Causes & Control 2/2000 Go to the issue

OriginalPaper

Deprived areas and attendance to screening of cervix uteri cancer in a French region

OriginalPaper

Hydatidiform moles and the long-term risk of breast cancer (Sweden)

OriginalPaper

Serum tocopherols, selenium and lung cancer risk among tin miners in China

OriginalPaper

Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden)

OriginalPaper

Vegetable and fruit consumption and lung cancer risk in the Netherlands Cohort Study on Diet and Cancer

OriginalPaper

Repeated measurements of organochlorine exposure and breast cancer risk (Denmark)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits